(MENAFN- America News Hour)
Kenneth Research recently added a report on 'Clinical Trial Imaging Market' in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on the COVID-19 impacts on the Clinical Trial Imaging Market, along with the compound growth rate (CAGR) of the market for a projected period between 2022 and 2031. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter's five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Clinical Trial Imaging Market products.
Download Sample of This Strategic Report:
Kenneth Research has recently added a report titled Clinical Trial Imaging Market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2021 2030. Factors such as the growing advancements in the development of novel drugs, coupled with the growing health infrastructure in several nations worldwide are anticipated to drive the growth of the market in the coming years. Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth.
According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.
Global Clinical Trial Imaging Market Analysis
According to Verified Market Research, the Global Clinical Trial Imaging Market was valued at USD 817 Million in 2017 and is projected to reach USD 1.2 Billion by 2025, growing at a CAGR of 6.3% from 2018 to 2025.
What is the purpose of Clinical Trial Imaging?
Clinical trial is an essential part of drug development process and the usage of medical imaging makes the clinical trials more accurate and effective. Clinical trial imaging provides the interpretable information of human anatomy/ physiology which is important in evaluating effect of drugs. It is mainly useful in prevention, detection and treatment of various medical conditions.
The Final Report will cover the impact analysis of COVID-19 on this industry:
Download Sample of This Strategic Report:
Global Clinical Trial Imaging Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and Restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Increase in pharma and biotech industries, increase in investments in R&D department and emerging economies in industry are the driving factors for the global clinical trial imaging market. While high cost of instalment and high cost of clinical trials acts a potential restraints for the overall market at a global level.
Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements which interests the client. The“Global Clinical Trial Imaging Market” is mainly bifurcated into sub-segments which can provide a classified data regarding latest trends in the market. This can be of a great use in gaining knowledge about the cutting-edge technologies in the market.
Global Clinical Trial Imaging Market Competitive Landscape
The“Global Clinical Trial Imaging Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Bioclinica, Inc., Parexel International Corporation, Icon PLC, Biomedical Systems Corporation, Biotelemetry, Inc., Cardiovascular Imaging Technologies, LLC, Intrinsic Imaging LLC, Ixico PLC, Radiant Sage LLC and Worldcare Clinical, LLC. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above mentioned players globally.
Global Clinical Trial Imaging Market, By Products And Services
• Services
• Operational Imaging Services
• Trial Design Consulting Services
• System and Technical Support Services
• Software
Global Clinical Trial Imaging Market, By Modality
• Computed Tomography
• Magnetic Resonance Imaging
• Positron Emission Tomography
• X-Ray
• Ultrasound
• Echocardiography
• Other Modalities
Global Clinical Trial Imaging Market, By End User
• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturers
• Contract Research Organizations
• Academic and Government Research Institutes
• Other End Users
Request For Full Report:
Global Clinical Trial Imaging Market Geographic Scope
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Latin America
o Brazil
• Rest of the World
RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.
About Us
Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defense, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.
MENAFN12042022004545010068ID1103996403
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.